Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), bought 690 shares at $29.77 ($21K) on 2011-08-11, disclosed to the SEC on 2011-08-11.
Open-market purchase of $21k SLXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.45 | 110 | $3K | 15.8% |
| 2 | $29.77 | 580 | $17K | 84.2% |
| Total | $29.72 avg | 690 | $21K | 100% |
| Filing → |
| SLXP | SELL | 2013-04-10 | $307K | — | Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |